Skip to content
Search

Latest Stories

New Australian law on vape sales infuriates pharmacists

New Australian law on vape sales infuriates pharmacists

Pharmacists fear this move will ultimately turn their premises into modern-day tobacconists 

UK Vaping Law :

Recently, Australia introduced a new law that restricts the sale of all types of vapes exclusively to pharmacies, as part of an effort to eliminate recreational vaping nationwide.

Controversially, pharmacies will soon be permitted to sell nicotine vapes without requiring a prescription under this law.


Although this initiative aims to improve national health, it has angered pharmacists, who fear it will ultimately turn their premises into modern-day tobacconists.

“This is just going to create more hassle for me,” a senior pharmacist told The Times.

In response to mounting concerns about a new generation becoming addicted to nicotine, the Labor government last Monday implemented a ban on the sale of all vapes, whether they contain nicotine or not, outside of pharmacies.

Australia has become the first country in the world to enact such a measure.

It is now illegal to domestically manufacture, supply, or commercially possess non-therapeutic and disposable vapes, with jail sentences of up to seven years and fines up to A$2.2 million (£1.16 million) for individuals, and A$22 million (£11.6 million) for businesses.

Vapes must now be sold in plain packaging, a regulation Australia first introduced over a decade ago for cigarettes.

Additionally, vapes are restricted to three flavours—tobacco, menthol, and mint—in an effort to eliminate overly sweet flavours like bubblegum and candy floss that tend to attract teenagers.

Furthermore, the nicotine concentration in vapes sold in pharmacies without a prescription will be limited to 20mg per ml — less than half the nicotine content found in many vapes sold on the black market.

Australia has implemented some of the world's strictest vaping laws. Since October 2021, it has been illegal to smoke e-cigarettes containing nicotine without a prescription, and in January, the import of disposable vapes was prohibited.

Despite these measures, vaping rates have surged among younger people and children, with cheap vapes being openly sold in corner shops, petrol stations, online, and even infiltrating school playgrounds.

The latest National Drug Strategy Household Survey revealed that the percentage of 14 to 17-year-olds who have tried e-cigarettes has nearly tripled from 9.6 per cent in 2019 to 28 per cent in 2022-23.

With e-cigarettes infiltrating school playgrounds, the percentage of 14 to 17-year-olds who have tried them has nearly tripled from 9.6 per cent in 2019 to 28 per cent in 2022-23, according to the latest National Drug Strategy Household Survey.

The UK is currently deliberating on legislation concerning the supply of tobacco, vapes, and related products.

If approved, the Tobacco and Vapes Bill will ban the sale of tobacco to children under 15, in line with former Prime Minister Rishi Sunak's commitment to achieve a smoke-free generation.

Introduced to the UK Parliament on March 20, the bill will also grant new powers to restrict vape flavours and packaging targeted at children, as well as relocate them out of sight and away from products appealing to youth, such as sweets.

Furthermore, enforcement officers will gain enhanced powers, including issuing on-the-spot fines of £100 to ensure compliance with the new laws, in addition to the existing maximum fine of £2,500 that local authorities can impose. Providing free samples of vapes to children under 18 will also become illegal.

Smoking, recognized as the UK's largest preventable cause of death, is estimated to cost the NHS and economy £17 billion annually.

Separately, under environmental legislation, the sale and supply of disposable vapes will be prohibited in England starting April 2025.

Official figures revealed that the number of children using vapes has tripled in the past three years, with nine per cent of 11 – to 15-year-olds now affected by this rising trend in the UK.

Disposable vapes are believed to be mainly driving the worrisome rise in youth vaping, with the number of 11- to 17-year-old vapers using disposables estimated to have increased by almost ninefold in the last two years.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less